As of 2026-06-11, the Intrinsic Value of Xylem Inc (XYL) is 150.57 USD. This Xylem valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 107.13 USD, the upside of Xylem Inc is 40.60%.
The range of the Intrinsic Value is 105.87 - 266.49 USD
Based on its market price of 107.13 USD and our intrinsic valuation, Xylem Inc (XYL) is undervalued by 40.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 105.87 - 266.49 | 150.57 | 40.6% |
| DCF (Growth 10y) | 136.85 - 326.05 | 189.90 | 77.3% |
| DCF (EBITDA 5y) | 124.97 - 142.28 | 133.51 | 24.6% |
| DCF (EBITDA 10y) | 152.05 - 185.42 | 167.95 | 56.8% |
| Fair Value | 103.18 - 103.18 | 103.18 | -3.69% |
| P/E | 107.16 - 128.53 | 115.41 | 7.7% |
| EV/EBITDA | 110.57 - 141.23 | 119.85 | 11.9% |
| EPV | 38.27 - 50.56 | 44.41 | -58.5% |
| DDM - Stable | 39.75 - 125.86 | 82.80 | -22.7% |
| DDM - Multi | 90.43 - 215.62 | 126.65 | 18.2% |
| Market Cap (mil) | 25,463.73 |
| Beta | 0.98 |
| Outstanding shares (mil) | 237.69 |
| Enterprise Value (mil) | 26,593.73 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.11% |
| Cost of Debt | 4.25% |
| WACC | 8.70% |